The document analyzes 1,720 validation observations from a project to identify common validation errors. The top nine most frequent errors were: missing information, inconsistency, lack of detail, traceability issues, vague wording, unverifiable test results, GDP issues, incomplete testing, and ambiguity. Specifications, test scripts, validation plans, test plans, trace matrices, and test results were the most vulnerable documents. Identifying and addressing common errors can help companies prepare for FDA inspections.